{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:18:28Z","timestamp":1787789908553,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Basic to Translational Science"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacbts.2026.101620","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T21:23:41Z","timestamp":1783373021000},"page":"101620","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Atibuclimab (IC14) for Treatment of Acute Decompensated Heart Failure"],"prefix":"10.1016","volume":"11","author":[{"given":"Antonio","family":"Abbate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0141-0127","authenticated-orcid":false,"given":"Michele","family":"Golino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin C.","family":"Hogwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Marchetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio I.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazmin","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1342-7463","authenticated-orcid":false,"given":"Justin M.","family":"Canada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Farr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Kontos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Federmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Priday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Mezzaroma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Toldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Agosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian W.","family":"Ziegelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W.","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Charmley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garry","family":"Redlich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Van Tassell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacbts.2026.101620_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","article-title":"Heart failure","volume":"1","author":"Braunwald","year":"2013","journal-title":"JACC Heart Fail"},{"issue":"9","key":"10.1016\/j.jacbts.2026.101620_bib2","doi-asserted-by":"crossref","first-page":"e275","DOI":"10.1161\/CIR.0000000000001412","article-title":"2026 Heart Disease and Stroke Statistics: a report of US and global data from the American Heart Association","volume":"153","author":"Palaniappan","year":"2026","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacbts.2026.101620_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jacc.2023.05.040","article-title":"Global comparison of readmission rates for patients with heart failure","volume":"82","author":"Foroutan","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"23","key":"10.1016\/j.jacbts.2026.101620_bib4","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.jacc.2024.03.405","article-title":"Left ventricular function, congestion, and effect of empagliflozin on heart failure risk after myocardial infarction","volume":"83","author":"Udell","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.jacbts.2026.101620_bib5","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1161\/ATVBAHA.124.319980","article-title":"Novel therapeutics and upcoming clinical trials targeting inflammation in cardiovascular diseases","volume":"44","author":"Potere","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.jacbts.2026.101620_bib6","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/FJC.0000000000001497","article-title":"Interleukin-1 inhibition for the prevention and treatment of heart failure","volume":"83","author":"Jafree","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"issue":"9","key":"10.1016\/j.jacbts.2026.101620_bib7","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.jacbts.2026.101620_bib8","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1161\/CIRCULATIONAHA.118.038010","article-title":"Anti-inflammatory therapy with canakinumab for the prevention of hospitalization for heart failure","volume":"139","author":"Everett","year":"2019","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacbts.2026.101620_bib9","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.jacbts.2026.101620_bib10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.molimm.2014.05.008","article-title":"Toll-like receptor co-receptors as master regulators of the immune response","volume":"63","author":"Di Gioia","year":"2015","journal-title":"Mol Immunol"},{"issue":"11","key":"10.1016\/j.jacbts.2026.101620_bib11","article-title":"CD14 blockade modulates macrophage-mediated immunological injury in a translational model of reperfused ST-segment elevation myocardial infarction","volume":"10","author":"D\u2019Elia Nee Brown","year":"2025","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.jacbts.2026.101620_bib12","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cca.2015.06.026","article-title":"Presepsin (sCD14-ST), an innate immune response marker in sepsis","volume":"450","author":"Chenevier-Gobeaux","year":"2015","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.jacbts.2026.101620_bib13","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.5114\/amsad.2017.66827","article-title":"Presepsin (sCD14-ST): could it be a novel marker for the diagnosis of ST elevation myocardial infarction?","volume":"2","author":"Caglar","year":"2017","journal-title":"Arch Med Sci Atheroscler Dis"},{"issue":"2","key":"10.1016\/j.jacbts.2026.101620_bib14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.15511\/ejcm.18.00260","article-title":"Serum presepsin levels in patients with decompensated heart failure","volume":"6","author":"B\u0131y\u0131k","year":"2018","journal-title":"J Updates Cardiovasc Med"},{"issue":"6","key":"10.1016\/j.jacbts.2026.101620_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/cvr\/cvz336","article-title":"Cardiac monocytes and macrophages after myocardial infarction","volume":"116","author":"Peet","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10.1016\/j.jacbts.2026.101620_bib16","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.cardfail.2020.03.003","article-title":"Soluble CD14 and risk of heart failure and its subtypes in older adults","volume":"26","author":"Al-Kindi","year":"2020","journal-title":"J Card Fail"},{"issue":"6","key":"10.1016\/j.jacbts.2026.101620_bib17","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014241","article-title":"Soluble CD14, ischemic stroke, and coronary heart disease risk in a prospective study: the REGARDS cohort","volume":"9","author":"Olson","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.jacbts.2026.101620_bib18","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1161\/ATVBAHA.112.300421","article-title":"Soluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adults","volume":"33","author":"Reiner","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"10.1016\/j.jacbts.2026.101620_bib19","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1002\/mus.27775","article-title":"Safety and activity of anti-CD14 antibody IC14 (atibuclimab) in ALS: experience with expanded access protocol","volume":"67","author":"Gelevski","year":"2023","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.jacbts.2026.101620_bib20","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jacbts.2026.101620_bib21","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC State-of-the-Art Review","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacbts.2026.101620_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2018.06.004","article-title":"Guidelines for performing a comprehensive transthoracic echocardiographic examination in adults: recommendations from the American Society of Echocardiography","volume":"32","author":"Mitchell","year":"2019","journal-title":"J Am Soc Echocardiogr"},{"issue":"6","key":"10.1016\/j.jacbts.2026.101620_bib23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna","year":"2020","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jacbts.2026.101620_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104667","article-title":"Phase 2, randomized, double-blind, placebo-controlled multi-center trial of the clinical and biological effects of anti-CD14 treatment in hospitalized patients with COVID-19 pneumonia","volume":"93","author":"Mabrey","year":"2023","journal-title":"EBioMedicine"},{"issue":"5","key":"10.1016\/j.jacbts.2026.101620_bib25","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.4049\/jimmunol.166.5.3599","article-title":"IC14, an anti-CD14 antibody, inhibits endotoxin-mediated symptoms and inflammatory responses in humans","volume":"166","author":"Verbon","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jacbts.2026.101620_bib26","article-title":"I-SPY COVID Consortium. Report of the first seven agents in the I-SPY COVID trial: a phase 2, open label, adaptive platform randomised controlled trial","volume":"58","year":"2023","journal-title":"EClinicalMedicine"},{"issue":"1","key":"10.1016\/j.jacbts.2026.101620_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.chstcc.2024.100117","article-title":"Anti-CD14 treatment in patients with severe COVID-19: clinical and biological effects in a phase 2 randomized open-label adaptive platform clinical trial","volume":"3","author":"Mabrey","year":"2025","journal-title":"CHEST Crit Care"},{"issue":"2","key":"10.1016\/j.jacbts.2026.101620_bib28","doi-asserted-by":"crossref","first-page":"100131","DOI":"10.1016\/j.chstcc.2025.100131","article-title":"Why biomarker-guided strategies shape the future of randomized controlled trials for immunomodulating therapies","volume":"3","author":"Michels","year":"2025","journal-title":"CHEST Crit Care"},{"key":"10.1016\/j.jacbts.2026.101620_bib29","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.yjmcc.2022.08.014","article-title":"CD14 inhibition mitigates left ventricular damage and dysfunction following myocardial infarction","volume":"173","author":"Brown","year":"2022","journal-title":"J Mol Cell Cardiol"},{"issue":"42","key":"10.1016\/j.jacbts.2026.101620_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000027421","article-title":"Phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis","volume":"100","author":"Henderson","year":"2021","journal-title":"Medicine (Baltimore)"}],"container-title":["JACC: Basic to Translational Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26001397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452302X26001397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:32:00Z","timestamp":1787787120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452302X26001397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2452302X26001397"],"URL":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101620","relation":{},"ISSN":["2452-302X"],"issn-type":[{"value":"2452-302X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atibuclimab (IC14) for Treatment of Acute Decompensated Heart Failure","name":"articletitle","label":"Article Title"},{"value":"JACC: Basic to Translational Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacbts.2026.101620","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"101620"}}